 |
PDBsum entry 4u6c
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.11.18
- methionyl aminopeptidase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Release of N-terminal amino acids, preferentially methionine, from peptides and arylamides.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Cobalt cation
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Med Chem
58:2350-2357
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases.
|
|
T.Arya,
R.Reddi,
C.Kishor,
R.J.Ganji,
S.Bhukya,
R.Gumpena,
S.McGowan,
M.Drag,
A.Addlagatta.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The methionine aminopeptidase (MetAP) family is responsible for the cleavage of
the initiator methionine from newly synthesized proteins. Currently, there are
no small molecule inhibitors that show selectivity toward the bacterial MetAPs
compared to the human enzyme. In our current study, we have screened 20
α-aminophosphonate derivatives and identified a molecule (compound 15) that
selectively inhibits the S. pneumonia MetAP in low micromolar range but not the
human enzyme. Further bioinformatics, biochemical, and structural analyses
suggested that phenylalanine (F309) in the human enzyme and methionine (M205) in
the S. pneumonia MetAP at the analogous position render them with different
susceptibilities against the identified inhibitor. X-ray crystal structures of
various inhibitors in complex with wild type and F309M enzyme further
established the molecular basis for the inhibitor selectivity.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |